Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease
Public ClinicalTrials.gov record NCT00316121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Randomized Study Comparing the Use of HEALOS® to Autograft in a Transforaminal Lumbar Interbody Fusion (TLIF) Approach
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and effectiveness of HEALOS compared with autograft using the transforaminal lumbar interbody fusion (TLIF) method.
Study identification
- NCT ID
- NCT00316121
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 138 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2006 (Type not available)
- Primary completion
- Jan 2010 (Actual)
- Completion
- Not listed
- Last update posted
- Mar 3, 2011
Started 2006
United States locations
- U.S. sites
- 17
- U.S. states
- 16
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Brandon | Florida | 33511 | — |
| Not listed | Jacksonville | Florida | 32204 | — |
| Not listed | Savannah | Georgia | 31405 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Annapolis | Maryland | 21401 | — |
| Not listed | Billings | Montana | 59101 | — |
| Not listed | Williamsville | New York | 14221 | — |
| Not listed | Norwood | Ohio | 45212 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Eugene | Oregon | 97401 | — |
| Not listed | Temple | Texas | 76508 | — |
| Not listed | Salt Lake City | Utah | 84108 | — |
| Not listed | Spokane | Washington | 99218 | — |
| Not listed | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00316121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2011 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00316121 live on ClinicalTrials.gov.